In patients with HIV-1 infection who are starting combination antiretroviral therapy (ART), the
incidence of immune reconstitution inflammatory syndrome (IRIS) is not well defined. We did …

The life cycle of Kaposi's sarcoma-associated herpesvirus (KSHV) consists of two phases,
latent and lytic. The virus establishes latency as a strategy for avoiding host immune …

Kaposi sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8, is
the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric …

The linkage of Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …

Kaposi sarcoma (KS) is the most common neoplasm of people living with HIV today. In Sub-
Saharan Africa, KS is among the most common cancers in men, overall. Not only HIV …

Access to antiretroviral therapy (ART) is improving worldwide. Immune reconstitution
inflammatory syndrome (IRIS) is a common complication of ART initiation. In this review, we …

Individuals with human immunodeficiency virus infection who commence antiretroviral
therapy when they are very immunodeficient are susceptible to immune reconstitution …

This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

The immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients initiating
antiretroviral therapy (ART) results from restored immunity to specific infectious or non …

Kaposi sarcoma (KS) remains a challenge. Its classic or Mediterranean form tends to be
benign. In transplant recipients it may be less so. As part of the AIDS pandemic, of which it …